Oslo Pensjonsforsikring AS Acquires Shares of 1,964 Cigna Group $CI

Oslo Pensjonsforsikring AS bought a new position in Cigna Group (NYSE:CI) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,964 shares of the health services provider’s stock, valued at approximately $524,000.

Several other institutional investors and hedge funds have also made changes to their positions in CI. Norges Bank acquired a new position in Cigna Group in the 4th quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after purchasing an additional 3,141,844 shares during the last quarter. Dodge & Cox grew its stake in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares in the last quarter. Boston Partners grew its position in shares of Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after buying an additional 1,243,056 shares in the last quarter. Finally, GQG Partners LLC grew its holdings in Cigna Group by 14.3% during the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after acquiring an additional 972,302 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE:CI opened at $289.82 on Wednesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The company has a market capitalization of $76.67 billion, a PE ratio of 12.29, a price-to-earnings-growth ratio of 1.09 and a beta of 0.29. The stock has a fifty day moving average of $286.41 and a 200-day moving average of $280.59.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the business posted $6.74 EPS. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CI has been the topic of several research reports. Raymond James Financial set a $340.00 price objective on Cigna Group in a research note on Friday, May 1st. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $310.00 to $304.00 in a research note on Tuesday, May 26th. Guggenheim increased their target price on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Piper Sandler cut their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $338.80.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.